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BACKGROUND: Clinical recommendations to limit gestational weight gain (GWG) imply high GWG is causally related to adverse
outcomes in mother or offspring, but GWG is the sum of several inter-related complex phenotypes (maternal fat deposition and
vascular expansion, placenta, amniotic ﬂuid and fetal growth). Understanding the genetic contribution to GWG could help clarify
the potential effect of its different components on maternal and offspring health. Here we explore the genetic contribution to total,
early and late GWG.
PARTICIPANTS AND METHODS: A genome-wide association study was used to identify maternal and fetal variants contributing to
GWG in up to 10 543 mothers and 16 317 offspring of European origin, with replication in 10 660 mothers and 7561 offspring.
Additional analyses determined the proportion of variability in GWG from maternal and fetal common genetic variants and the
overlap of established genome-wide signiﬁcant variants for phenotypes relevant to GWG (for example, maternal body mass index
(BMI) and glucose, birth weight).
RESULTS: Approximately 20% of the variability in GWG was tagged by common maternal genetic variants, and the fetal genome
made a surprisingly minor contribution to explain variation in GWG. Variants near the pregnancy-speciﬁc beta-1 glycoprotein 5
(PSG5) gene reached genome-wide signiﬁcance (P= 1.71 × 10− 8) for total GWG in the offspring genome, but did not replicate. Some
established variants associated with increased BMI, fasting glucose and type 2 diabetes were associated with lower early, and
higher later GWG. Maternal variants related to higher systolic blood pressure were related to lower late GWG. Established maternal
and fetal birth weight variants were largely unrelated to GWG.
CONCLUSIONS:We found a modest contribution of maternal common variants to GWG and some overlap of maternal BMI, glucose
and type 2 diabetes variants with GWG. These ﬁndings suggest that associations between GWG and later offspring/maternal
outcomes may be due to the relationship of maternal BMI and diabetes with GWG.
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INTRODUCTION
High and low levels of gestational weight gain (GWG), deﬁned as
the weight a woman gains during pregnancy before delivery of
her infant,1 are associated with a wide range of adverse outcomes
for mother and child in the short term (during pregnancy and the
perinatal period), and long term.2–9 As a consequence of these
associations, recommendations for healthy GWG are increasingly
used in antenatal care,1 despite a lack of evidence that any of
these associations are causal, and if they are, what the
mechanisms underlying them might be.3,10 GWG is a complex
phenotype that is inﬂuenced by maternal responses to pregnancy,
such as gestational fat deposition and volume expansion, as well
as fetal growth, placental size and amniotic ﬂuid volume.3,10 Each
of these are likely to be inﬂuenced both by maternal and fetal
genes and environmental exposures. Understanding the maternal
and fetal genetic contributions to GWG could shed light on both
genetic and non-genetic contributions to between woman
variation in GWG.11,12 For example, we have recently used
maternal genetic instrumental variables to determine the causal
effect of maternal pregnancy adiposity and related traits on
offspring birth weight and ponderal index.13
Among 1159 European origin Swedish maternal twin pairs (694
pairs with data on their ﬁrst pregnancies and 465 on their second),
it has been shown that approximately 40% of variability in ﬁrst
pregnancy GWG was due to genetic factors.14 Other studies have
examined the associations of candidate maternal and/or fetal
adiposity or diabetes related genetic variants with GWG and
yielded inconsistent results; however, these studies have had
small sample sizes, been conducted in single studies and have not
sought independent replication.15–17 To our knowledge, no
previous genome-wide association study (GWAS) of GWG has
been conducted.
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The aim of this study was to increase understanding of the
genetic and non-genetic determinants of GWG by (a) estimating
the proportion of variation in total, early and late GWG tagged by
maternal and fetal common genetic variants; (b) undertaking a
GWAS of maternal and fetal genetic variants with total, early and
late GWG, and attempting to replicate associations in independent
samples and (c) determining the associations of genetic variants
from GWAS of phenotypes that are plausible contributors to GWG
(that is, birth weight, body mass index (BMI), waist-hip ratio,
height, blood pressure, glucose, type 2 diabetes and vitamin D)
with total, early and late GWG. We examined associations of
maternal and fetal genetic exposures with total, early and late
GWG, because the relative contribution of maternal and fetal
phenotypes to GWG vary across gestation. For example, maternal
fat deposition contributes relatively more to early GWG (up to
~ 18–20 weeks of gestation), and fetal growth more to later
GWG.3,10 We included vitamin D (25(OH)D) as a phenotype that
plausibly contributes to GWG as maternal 25(OH)D may have a
positive affect on birth weight,13 and therefore may have a
positive association with GWG.
MATERIALS AND METHODS
We included singleton pregnancies of mother–offspring pairs of European
origin from 20 pregnancy/birth cohorts, described in detail in
Supplementary material and Supplementary Table 1. Pregnancies that
resulted in a miscarriage or stillbirth, those with a known congenital
anomaly and those where delivery was preterm (before 37 completed
weeks of gestation) were excluded.
Total GWG was deﬁned as the last gestational weight (as long as this
was ⩾ 28 weeks of gestation) before delivery minus pre-/early-pregnancy
weight divided by the length of gestation in weeks at the last
measurement. Pre/early-pregnancy weight was deﬁned as maternal self-
reported pre-pregnancy weight (with this report collected during
pregnancy), a research/clinical measure of weight before pregnancy (with
that measure taken no412 weeks before predicted date of conception) or
the ﬁrst antenatal clinic weight (with that assessment ⩽ 13 weeks of
gestation), which ever was the earliest. Early GWG was the difference
between pre-/early-pregnancy weight and weight measured any time
between 18 and 20 (inclusive) completed weeks of gestation divided by
length of gestation in weeks at the time of the 18- to 20-week
measurement. Late GWG was the difference between the 18- and 20-
week measurement and the last gestational weight measure at ⩾ 28 weeks
of gestation divided by the gestational age difference in completed weeks
between these two measurements. Although we were interested in the
possibility that different maternal and fetal genetic variants might
contribute to early and late GWG (as discussed in the ﬁnal paragraph of
the introduction), we considered total GWG to be our main outcome. The
rationale for this was: (a) this was the phenotype for which we had most
data and therefore greatest statistical power; (b) the majority of
epidemiological studies relating GWG to subsequent maternal and
offspring outcomes use total GWG;2,3,7,18 and (c) recommendations
regarding optimal GWG use total GWG.1 Similarly, the gestational ages
used to deﬁne early and late GWG were based several factors:
(a) maximizing sample sizes for both early and late GWG, which for many
studies reﬂected times in pregnancy when women are routinely weighed;
(b) evidence that the relative (to maternal contribution) fetal contribution
to GWG becomes greater from 16 to 20 weeks of gestation;1,19 and
(c) applying multilevel models to the very detailed repeat measurements
of gestational weight in the Avon Longitudinal Study of Parents and
Children (ALSPAC), in which the median (interquartile range) of measure-
ments per woman was 12,9–13 demonstrated changes in the amount of
weight gained per week of gestation at 18 and 28 weeks.4,20,21 Other
epidemiological studies report differences in GWG from around 14 to
15 weeks of pregnancy, but as discussed in previous reviews, this if often
driven by selecting measures around traditional trimesters (14 weeks being
the time at which the second trimester begins).1,2 In studies with repeated
measurements between 18 and 20 weeks, the one nearest to 18 weeks was
used and in those with repeated later measurements the last weight was
deﬁned as the one nearest to (but before) delivery. Total, early and late
GWG s.d. (z-) scores were calculated within each study as the participant
value minus the individual study mean then divided by the study s.d.
Proportion of variation in total, early and late GWG, and birth
weight that is due to maternal and fetal common genetic variants
We used methods that have been developed for use with genome-wide
data to estimate the proportion of variation in total, early and late GWG,
and birth weight tagged by maternal and fetal common genetic variants.
Genetic restricted maximum likelihood (GREML)22 and maternal genome-
wide complex trait analysis (M-GCTA)23 were applied to maternal and fetal
genome-wide data from ALSPAC. The M-GCTA model uses similarity
between mothers and offspring in the genome-wide data to partition the
phenotypic variance in GWG into components due to the maternal
genotype, the child’s genotype, the covariance between the maternal and
child’s genotype and an environmental component.
ALSPAC is a prospective population-based birth cohort study that
recruited 14 541 pregnant women resident in Avon, UK with expected
dates of delivery between 1 April 1991 and 31 December 1992 (http://
www.alspac.bris.ac.uk.).24,25 GWG was determined using data extracted
from obstetric medical records by trained research midwives.5 Birth
weight, gestational age (in completed weeks) and fetal sex were obtained
from obstetric/perinatal records. Maternal genome-wide data were
obtained from the genome-wide Illumina 660K quad single nucleotide
polymorphism (SNP) chip (Illumina Inc., San Diego, CA, USA) at the Centre
National de Genotypage, Paris. Fetal genome-wide data were obtained
from the Illumina HumanHap550 quad genome-wide SNP genotyping
platform by 23 and Me subcontracting the Wellcome Trust Sanger
Institute, Cambridge, UK, and the Laboratory Corporation of America,
Burlington, NC, USA. Further details, including genotype imputation and
QC, are provided in online Supplementary material and characteristics of
the participants are described in Supplementary Table 1.
Maternal and fetal GWAS of total, early and late GWG
All studies are in the Early Growth Genetics (EGG) consortium (http://egg-
consortium.org/) with relevant data participated. Twenty independent
pregnancy/birth cohorts contributed to at least one discovery and/or
replication analysis (this included data from ALSPAC). Details of each of
these studies are provided in the Supplementary Material and study
participant characteristics, including their contribution to each GWAS, are
shown in Supplementary Table 1. For total GWG, up to 10 543 (including
participants from ALSPAC, DNBC-GOYA, DNBC-PTB and MoBa; see
Supplementary material for details of these cohorts) and 16 317
participants (from ALSPAC, DNBC-PTB, Generation R, INMA, LISAplus,
MoBa, NFBC-1966, PANIC, Raine, STRIP and TEENAGE; Supplementary
material) contributed to maternal and fetal discovery GWAS, respectively
(Supplementary Table 1 and Table 1). The numbers for early and late GWG
GWAS being somewhat lower (Table 1). Up to an additional 10 660 and
7561 participants contributed to maternal and fetal replication analyses
(see Supplementary Table 1 for cohorts included), with the maximum total
meta-analysis sample size for total GWG being 18 420 and 21 105 for
maternal and fetal GWAS, respectively.
All genotyping was undertaken by laboratory staff at each of the
contributing studies who were blinded to any phenotypic data. GWAS
discovery and replication analyses were undertaken independently by
analysts working with each of the contributing studies following a prior
agreed analysis plan. Genotypic data imputed to HapMap Phase 2 (Build
36, release 22) was used (methods for imputing within each contributing
study is described in the Supplementary Material) in the analysis, assuming
an additive genetic model and adjusting for fetal sex.
Fixed-effects, inverse-variance weighted meta-analyses in METAL26 were
undertaken to combine GWAS results from the individual discovery
studies. The most signiﬁcant SNPs in regions reaching suggestive
signiﬁcance (Po10− 5) in the discovery GWAS of any of the analyses
(that is, total, early or late GWG or in the maternal or fetal genome) were
taken forward to replication. This set of SNPs were analyzed against the
three phenotypes in the replication studies and the results were combined
using inverse-variance weighted meta-analysis in R (version 3.0.0) using
the rmeta package.27 In addition, to investigate whether this set of top
SNPs were more likely to be acting in the maternal or offspring genome to
inﬂuence GWG, conditional analysis was conducted in studies where both
maternal and fetal genotype were available. Again, the results from these
analyses were combined using inverse-variance weighted meta-analysis in
R (version 3.0.0). Computer code for the discovery and replication meta-
analyses is available from the ﬁrst author upon request.
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Maternal and fetal genetic variants for phenotypes with plausible
contributions to GWG
We examined the associations of a set of a priori agreed genetic variants
that had previously (in GWAS) been shown to be robustly associated with
phenotypes that might plausibly inﬂuence GWG with our GWG pheno-
types. These were genetic variants for birth weight, BMI, waist-hip ratio,
height, blood pressure, fasting glucose, type 2 diabetes and vitamin D (25
(OH)D). Supplementary Table 2 lists the variants included for each of the
traits. The results for each of the variants were extracted from the discovery
GWAS, and the replication studies provided results for the subset of
variants they had available. Inverse-variance weighted meta-analysis was
conducted in METAL26 to combine the results across all the cohorts. In
these hypothesis-driven analyses, we use a two-sided P-value of o0.05 as
indicating statistical signiﬁcance.
RESULTS
Total GWG was between 0.35 and 0.45 kg per week in all of the
general population studies and somewhat lower in the two
studies that combined severely obese women with lean or a
population cohort comparison group; in all studies early GWG was
considerably lower than late GWG (Supplementary Table 1). The
correlation between early (deﬁned as between pre-pregnancy and
18 weeks) and late GWG (18 weeks to delivery) and between early
and total GWG, in one of the largest contributing studies with data
on both periods (ALSPAC) were − 0.08 and − 0.11, respectively.
Proportion of variation in GWG and birth weight because of
maternal and fetal common genetic variants
SNPs across the genome explained broadly similar proportions of
variation in late GWG and early GWG, but with stronger
contributions of maternal compared with fetal genome, with
SNPs in the maternal genome explaining approximately twice the
amount of variation in total GWG than the fetal genome (Table 2).
The opposite pattern was seen for birth weight, for example, SNPs
across the maternal genome explained 24% (P= 1.94 × 10− 6) of
the variation in total GWG, with 12% (P= 0.008) explained by SNPs
in the fetal genome, whereas the maternal genome explained
13% (P= 0.02) and fetal genome 18% (P= 1.86 × 10− 3) of variation
in birth weight (Table 2). When we modeled maternal and fetal
contributions together this pattern remained, but with the
differences between maternal and fetal contributions increasing
somewhat; for total GWG 17% and 5%, respectively, for maternal
and fetal genome and for birth weight 4% and 24%, respectively,
for maternal and fetal genome, with relatively little covariance
between the two genomes for either trait. When the covariance
and offspring/maternal variance components were constrained to
zero in the M-GCTA model, similar results to the GREML analysis
were obtained (Supplementary Table 3).
Maternal and fetal GWAS of total, early and late GWG
There was no systematic inﬂation of the test statistics in the meta-
analysis of approximately 2.5 million SNPs (λmat-early = 1.01, λmat-
late = 1.01, λmat-total = 1.02, λoff-early = 1.02, λoff-late = 1.00, λoff-
total = 1.00; Supplementary Figure 1). In discovery analyses, one
variant, rs16989175 near the pregnancy-speciﬁc beta-1 glycopro-
tein 5 (PSG5) gene, reached conventional GWAS signiﬁcance
(Po5 × 10− 8) for fetal genetic association with total GWG; it also
showed some evidence of fetal association with late
(P= 2.4 × 10−3) and early (P= 0.02) GWG. However, it did not
replicate in either the maternal or fetal analysis. An additional nine
regions were identiﬁed as being suggestively signiﬁcant (Po
10− 5) for at least one phenotype in either maternal or fetal
genome (Supplementary Figure 2). These were taken forward to
replication analyses. Only one of these 10 SNPs replicated,
rs310087 near SYT4 (Table 1). This SNP was associated with total
GWG in the fetal genome (mean difference in total GWG per allele
0.06 (95% conﬁdence interval (CI): 0.04, 0.08) kg per week;T
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P= 3× 10− 6 in discovery samples and 0.05 (95% CI: 0.01, 0.09) kg
per week; P= 0.03 in replication samples and 0.06 (95% CI: 0.04,
0.08) kg per week; P= 1.6 × 10− 5 in pooled discovery and
replication). For 6 out of the 10 top SNPs identiﬁed (rs481396,
rs3924699, rs6457375, rs13295979, rs1702200 and rs7133083), the
point estimate was larger for the maternal genotype on total GWG
than the offspring genotype on this phenotype (Table 1). This was
suggested in conditional analyses, whereby the point estimates
for the offspring genotypes mostly attenuated after adjusting for
maternal genotype (Table 3). The variant near SYT4, that in the
fetal genome was nominally signiﬁcantly associated with total
GWG in discovery analyses and replicated, was not notably altered
with adjustment for the maternal variant. Summary statistics from
the discovery meta-analyses are available at http://egg-consor
tium.org/.
Association of maternal and fetal genotypes for phenotypes with
plausible contributions with GWG
Seven of the 32 BMI-associated SNPs showed evidence of
association (Po0.05) with early GWG using maternal genotype,
with ﬁve of the BMI increasing alleles associated with a decrease in
early GWG (Supplementary Figure 3). In contrast, only three of the
BMI-associated SNPs showed association with late GWG using
maternal genotype, and all three increased both BMI and GWG. A
similar pattern of association was seen with the SNPs associated
with glucose (Supplementary Figure 4) and type 2 diabetes
(Supplementary Figure 5), whereby alleles associated with
increased glucose/risk of type 2 diabetes showed evidence of
association of maternal genotype with decreased GWG in early
gestation and with increased GWG in late gestation. A smaller
portion of SNPs for these phenotypes using the offspring
genotype were associated with GWG (Supplementary Figures 3
to 5).
Surprisingly, none of the birth weight-associated SNPs using the
offspring genotype were associated with any GWG phenotype
(Supplementary Figure 6). However, the SNP with the largest
effect on birth weight (from fetal GWAS of birth weight), rs900400,
using the maternal genotype was associated with decreased late
GWG and total GWG, for each birth weight increasing allele. SNPs
associated with blood pressure, when using the maternal genome,
showed stronger association with late GWG than early GWG, with
the blood pressure increasing allele for most variants associating
with decreased GWG (Supplementary Figure 7). Offspring blood
pressure SNPs and SNPs associated with waist-hip ratio (maternal
or offspring; Supplementary Figure 8), vitamin D (25(OH)D)
(Supplementary Figure 9) or height (Supplementary Figure 10)
were not notably associated with any GWG phenotypes.
DISCUSSION
We have shown that approximately 20% of the variability in GWG
can be explained by common maternal genetic variants. A much
smaller contribution is made by common genetic variants from
the fetal genome. This pattern of maternal and fetal genetic
contribution is opposite to what we see with birth weight, for
which the fetal contribution is greater. Despite this modest
genetic contribution, which is similar to the common genetic
contribution to birth weight and many other phenotypes,28 in
what we believe to be the ﬁrst GWAS of GWG, we were unable to
identify any genetic variants that reached genome-wide levels of
signiﬁcance (Po5 × 10− 8) and that replicated. Given the possible
contribution of several adiposity-related phenotypes to overall
GWG, we also investigated whether genetic variants that are
known to be associated with these traits were also associated with
GWG. Some maternal BMI, fasting glucose and type 2 diabetes
variants were nominally associated with GWG, such that those that
were associated with increased BMI, glucose or type 2 diabetes,
were associated with lower early and higher late GWG. Some
maternal variants associated with higher systolic blood pressure
were also associated with lower late GWG. In general, fetal variants
associated with these traits were largely unrelated to GWG. Of
note, established maternal and fetal birth weight variants were for
the most part not related to GWG. The one exception being
rs900400, a variant previously shown to be strongly related to
birth weight in a genome-wide study of fetal genotype,29 which in
our study was inversely associated with late and total GWG in the
case of the maternal genotype. This variant has also been recently
shown to be inversely associated with leptin in genome-wide
analyses,30 and thus the inverse association of this variant in the
mother with GWG may reﬂect a positive association of maternal
leptin with GWG.
Using a twin study, Andersson et al.14 show that the heritability
of ﬁrst pregnancy GWG is 43%; we were able to show that
approximately half of this could be explained by common genetic
variants or variants they tag in the maternal genome. This is
similar to the proportion of heritability explained in other
common traits such as height and BMI.28 It is perhaps not
surprising that our results suggest that the maternal genome has a
greater contribution to GWG than the offspring genome. On
average, approximately 55% of GWG is a result of increased
maternal tissue, 15–20% is due to the placenta and amniotic ﬂuid,
and 20–25% is a result of fetal tissue.19 The maternal genome will
contribute to tissue expansion in the mother, as well as to
placental size, amniotic ﬂuid and fetal growth, whereas, it is likely
that the fetal genome will only contribute to placenta, amniotic
ﬂuid and fetal growth. We detected some evidence of a negative
genetic covariance in the M-GCTA analysis of late GWG. A negative
covariance implies that a proportion of maternal genetic variants
associated with increased GWG are associated with decreased
GWG when present in the fetal genome. Although this was a
Table 2. Estimates (s.e.) of proportion of maternal and fetal genetic contributions from common variants to gestational weight gain
GREML resultsa M-GCTA results
Maternal genome (N= 6435) Child genome (N= 6435) Maternal genome (N= 4078) Child genome (N= 4078) Covariance (N= 4078)
Early 0.195 (0.055) 0.058 (0.053) 0.021 (0.113) 0.000 (0.115) 0.067 (0.091)
Late 0.244 (0.054) 0.110 (0.053) 0.196 (0.113) 0.161 (0.114) − 0.039 (0.091)
Total 0.239 (0.055) 0.121 (0.053) 0.173 (0.112) 0.045 (0.113) 0.016 (0.090)
Birth weight 0.13 (0.06) 0.18 (0.06) 0.04 (0.10) 0.24 (0.11) 0.04 (0.08)
Abbreviations: GREML, genetic restricted maximum likelihood; GWG, gestational weight gain; M-GCTA, maternal genome-wide complex trait analysis.
aP-values for the GREML results are: maternal genome, early GWG= 1.12 × 10− 4, maternal genome, late GWG= 8.83 × 10−7, maternal genome, total
GWG= 1.94 × 10− 6, maternal genome, birth weight= 0.02, offspring genome, early GWG= 0.130, offspring genome, late GWG= 0.015, offspring genome, total
GWG= 0.008, offspring genome, birth weight= 1.86 × 10− 3.
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surprising result, it is not inconceivable. For example, there is a
well-described relationship between mutations in the glucokinase
gene (GCK) and offspring birth weight, whereby if the mutation is
present in the mother and not the offspring then the birth weight
is increased, whereas if the mutation is present in the offspring
but not the mother then the birth weight is decreased.31 Given
birth weight is a component of GWG, it is plausible that variants in
GCK and other mutations involved in insulin secretion could
produce similar effects on GWG. However, given the large
standard error on the estimate, this negative covariance might
be a chance ﬁnding and requires replication before any further
interpretation is made.
Our lack of replicated genome-wide signiﬁcant ﬁndings might
be due to the complexity of the GWG phenotype. Weight was
measured by trained personnel during pregnancy in the majority
of studies included in this meta-analysis, however, the pre-
pregnancy measure was often self-report and the early-pregnancy
measure would have included some pregnancy weight gain. This
would have increased the measurement error for GWG, making it
difﬁcult to identify true genetic associations. In addition, we had
low statistical power to detect associations with genetic variants,
which have a small effect. With an alpha of 5 × 10− 8 in the
maternal GWAS of total GWG, we had 80% power to detect a
genetic variant that explained between 0.37 and 0.4% of the
variance for our range of sample sizes (N= 9832–10 543). Similarly,
we had 80% power to detect a variant that explained 0.24–0.3% of
the variance in the offspring GWAS of total GWG (N= 12 995–
16 317). However, for other complex quantitative phenotypes,
such as BMI, the genetic variants discovered to date each explain
0.003–0.325% of the variance,32 indicating that many common
genetic variants each of small effect inﬂuence the trait. Therefore,
we had adequate power to detect common genetic variants with
modest to large effects, but we were unable to detect variants
with smaller effects, although we used the largest sample of
individuals for exploring genetic associations with this phenotype
to date and are unaware currently of other European origin
studies that could have added to this effort.
Despite most of our analyses suggesting a stronger contribution
of maternal, than fetal common genetic variants to GWG, the one
nominally signiﬁcant variant that replicated was for a fetal variant
that was related to total GWG. This variant on chromosome 18, is
near to the Synaptotagmin 4 (SYT4) gene, which is a protein-
coding gene involved in calcium and syntaxin binding.33 Its
relation to GWG is unclear and this association should be treated
with caution unless further replicated, particularly as the associa-
tion was only nominal and did not reach conventional GWAS
signiﬁcance of 5 × 10− 8 even in combined meta-analysis of
discovery and replication samples (the result being per allele
difference in mean total GWG: 0.06 (95% CI: 0.04, 0.08) kg per
week; P= 1.6 × 10− 5 in pooled discovery and replication).
There is little clear evidence linking most of the genes nearest
our top 10 loci to GWG. However, some speculative evidence
exists for the following nearest genes. The gene nearest our
strongest association in the discovery GWAS was PSG5, which
belongs to a group of molecules that are mainly produced during
pregnancy by the placental syncytiotrophoblasts. Pregnancy-
speciﬁc beta-1 glycoprotein (PSBG) levels have been correlated
with placental function and fetal well-being.34 TMEM163, which
harbors rs481396, is a putative zinc transporter.35 Zinc has been
shown to be positively correlated with birth weight.36 Two of the
genes nearest to the index SNPs taken forward for replication
have previously been associated with adult height,37 LCORL and
HLA-C. LCORL has also been associated with birth weight29 and
birth length,38 which might be driving the association with GWG.
HLA-C, being part of the major histocompatibility complex on
chromosome 6 has also been associated with various auto-immune
diseases such as psoriasis, Crohn’s disease and atopic-dermatitis.
Variants in TCERG1L have been shown to be associated with fastingT
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insulin and insulin resistance in an African–American population,39
which could have implications for growth of both the mother and
the offspring.
We expanded on previous studies that examined the associa-
tions of candidate maternal and/or fetal adiposity or diabetes
related genetic variants with GWG15–17 by looking at a wider
variety of phenotypes that are observationally related to GWG
(previous studies looked only at BMI and type 2 diabetes), in a
considerably larger sample of participants and using a greater
number of variants for each phenotype. We are aware that for
some of the phenotypes investigated, there are a larger number of
associated SNPs in the more recent GWAS, for example, over 90
variants have now been shown to independently relate to BMI.32
The subset of variants that we used for each phenotype were
those with the largest effect sizes on each of the individual traits
and that were available in the majority of replication (as well as
discovery) samples, therefore we will have greater power to detect
an effect with GWG if one exists.
The main strength of this study was the availability of both
maternal and offspring genotype and the three separate
phenotypes for GWG allowing us to investigate whether genetic
variants had consistent effects throughout pregnancy. Our main
analyses explored genetic contributions to total GWG. This
enabled us to maximize our sample size, but it assumes that
weight gain is linear across gestation. Evidence suggests that GWG
is slower in early pregnancy up to 14–18 weeks depending on
how it is measured and the population studied, but for the
majority of pregnancy from this time point it is broadly linear.1,20
Furthermore, we examined associations (in smaller subsets) with
early and late GWG. The choice of 18–20 weeks to distinguish
between early and late GWG was determined on the basis of
maximizing sample sizes, evidence for differences in fetal and
maternal contributions before and after this time,1,19 and multi-
level modeling in the ALSPAC cohort, which was the largest
contributing cohort to our study with multiple repeated weight
measures throughout pregnancy.20 The weak correlation between
early and late GWG in our largest cohort contributing to these
measures, supports these two periods being relatively indepen-
dent of each other. GWG varies by pre- or early-pregnancy BMI
and other characteristics such as parity and ethnicity,2 and some,
but not all, studies suggest that associations of GWG with
maternal and offspring outcomes varies by maternal BMI; the
review that informed the Institute of Medicine recommendations
for GWG noted that even for associations with outcomes that
appeared to vary by BMI these subgroup analyses could not be
considered robust.2 We were interested here in maternal and fetal
genetic contributions to GWG in whole populations, and as with
other studies of candidate genes with GWG, we have not looked
at whether GWAS results would differ by maternal BMI. We would
have limited power to do so and would be concerned about
spurious subgroup ﬁndings from such analyses. We acknowledge
that further analyses in studies that would enable more reﬁned
GWAS of trajectories of GWG across pregnancy, and with larger
sample sizes that could explore possible interactions with
maternal characteristics, such as BMI, ethnicity and parity, would
be beneﬁcial. However, our knowledge of the literature and
potentially suitable studies suggests that currently only ALSPAC
has detailed repeat measurements together with genome-wide
data on mothers and offspring and it alone is too small to be
adequately powered for such analyses. Furthermore, we have
made every effort to engage with all cohorts that have both
genetic and phenotypic data. Despite being the ﬁrst large GWAS
of this trait, to our knowledge and our effort to include all studies
of European origin women with relevant data, we had limited
power to detect variants with weak effects and will continue to
seek additional studies to contribute to large GWAS in the future.
In summary, we have identiﬁed that a substantial proportion of
the variation in GWG can be explained by common variants in the
maternal genome, with an additional smaller proportion being
explained by the offspring genome. In what we believe to be the
ﬁrst GWAS of GWG, using the largest collection of individuals, we
were unable to identify any loci with a large effect on GWG and
that replicated, but found some evidence that maternal variants
may contribute more to GWG than fetal variants. These initial
results suggest that the association of GWG with later offspring
outcome may reﬂect intrauterine (maternal) effects. However,
given the composite nature of GWG, including increasing
maternal fat stores and plasma volume, the growing fetus,
placenta and amniotic ﬂuid, larger sample sizes are required to
identify individual genetic loci for GWG.
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